Eva Fortea-Verdejo Analyst PerformanceBiotech equity research analyst at Wells Fargo & CompanyEva Fortea-Verdejo is a stock analyst at Wells Fargo & Company in the healthcare sector, covering 15 publicly traded companies. Over the past year, Eva Fortea-Verdejo has issued 36 stock ratings, including buy, hold, and sell recommendations. While full access to Eva Fortea-Verdejo's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Eva Fortea-Verdejo's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings47 Last 1 YearsBuy Recommendations61.70% 29 Buy RatingsCompanies Covered15 Unique Companies Ratings Distribution47RatingsDistribution of strong buy, buy, hold, and sell ratings by Eva Fortea-Verdejo.RatingPercentageCount Strong Buy0.0%0 ratings Buy61.7%29 ratings Hold34.0%16 ratings Sell4.3%2 ratingsOut of 47 total stock ratings issued by Eva Fortea-Verdejo at Wells Fargo & Company, the majority (61.7%) have been Buy recommendations, followed by 34.0% Hold and 4.3% Sell.Best & Worst CallsBest Call0000.0%RVMDSep 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%XNCRFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ93.3% of companies on NASDAQ14 companiesNYSE6.7% of companies on NYSE1 companyEva Fortea-Verdejo, an analyst at Wells Fargo & Company, currently covers 15 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare15 companies100.0%Eva Fortea-Verdejo of Wells Fargo & Company specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY15 companies100.0% Eva Fortea-Verdejo's Ratings History at Wells Fargo & Company Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsKNSAKiniksa Pharmaceuticals International9/30/2026Initiated Coverage$75.15$87.00Overweight$0.0000.00% ROIBCAXBicara Therapeutics8/12/2026Boost Price Target$23.76$23.00Equal Weight$0.0000.00% ROIZYMEZymeworks8/7/2026Boost Price Target$23.13$40.00Overweight$0.0000.00% ROIRCUSArcus Biosciences8/6/2026Boost Price Target$27.58$26.00Equal Weight$0.0000.00% ROIEXELExelixis7/13/2026Boost Price Target$56.26$49.00Equal Weight$0.0000.00% ROIKNSAKiniksa Pharmaceuticals International7/13/2026Boost Price Target$63.44$74.00Overweight$0.0000.00% ROIZYMEZymeworks6/30/2026Boost Price Target$24.10$37.00Overweight$0.0000.00% ROINUVLNuvalent6/9/2026Reiterated Rating$123.21$124.00Equal Weight$0.0000.00% ROINUVLNuvalent6/9/2026Downgrade$123.25$124.00Equal Weight$0.0000.00% ROICELCCelcuity6/3/2026Lower Price Target$91.42$166.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. CELCCelcuity5/15/2026Boost Price Target$134.72$183.00Overweight$0.0000.00% ROIZYMEZymeworks5/8/2026Boost Price Target$25.12$34.00Overweight$0.0000.00% ROIEXELExelixis5/6/2026Boost Price Target$45.99$40.00Equal Weight$0.0000.00% ROIKNSAKiniksa Pharmaceuticals International4/29/2026Boost Price Target$53.89$57.00Overweight$0.0000.00% ROIRLAYRelay Therapeutics4/28/2026Boost Price Target$14.95$21.00Overweight$0.0000.00% ROIIDYAIDEAYA Biosciences4/14/2026Boost Price Target$31.45$48.00Overweight$0.0000.00% ROIBCAXBicara Therapeutics3/31/2026Boost Price Target$19.52$16.00Equal Weight$0.0000.00% ROINUVLNuvalent3/30/2026Initiated Coverage$96.66$116.00Overweight$0.0000.00% ROISTROSutro Biopharma3/24/2026Upgrade$21.33$27.00Overweight$0.0000.00% ROIRLAYRelay Therapeutics3/17/2026Boost Price Target$10.13$17.00Overweight$0.0000.00% ROIGMABGenmab A/S3/2/2026Initiated Coverage$29.44$40.00Overweight$0.0000.00% ROIRLAYRelay Therapeutics2/27/2026Boost Price Target$10.59$15.00Overweight$0.0000.00% ROIKNSAKiniksa Pharmaceuticals International2/25/2026Boost Price Target$41.86$53.00Overweight$0.0000.00% ROIRCUSArcus Biosciences2/12/2026Set Price Target$21.37$23.00Equal Weight$0.0000.00% ROIRCUSArcus Biosciences2/12/2026Downgrade$19.88$23.00Equal Weight$0.0000.00% ROIEXELExelixis2/11/2026Boost Price Target$42.17$35.00Equal Weight$0.0000.00% ROIRLAYRelay Therapeutics12/12/2025Upgrade$7.79$13.00Overweight$0.0000.00% ROIZYMEZymeworks12/12/2025Upgrade$24.94$33.00Overweight$0.0000.00% ROIZYMEZymeworks11/19/2025Boost Price Target$22.99$25.00Cautious$0.0000.00% ROIBCAXBicara Therapeutics11/11/2025Boost Price Target$13.84$11.00Equal Weight$0.0000.00% ROIZYMEZymeworks11/7/2025Boost Price Target$16.80$17.00Equal Weight$0.0000.00% ROIRLAYRelay Therapeutics11/7/2025Boost Price Target$6.19$6.00Equal Weight$0.0000.00% ROIIMCRImmunocore10/31/2025Initiated Coverage$32.19$60.00Overweight$0.0000.00% ROIIMCRImmunocore10/31/2025Initiated Coverage$32.38$60.00Overweight$0.0000.00% ROIZYMEZymeworks10/24/2025Initiated Coverage$17.41$15.00Equal Weight$0.0000.00% ROIRCUSArcus Biosciences10/20/2025Boost Price Target$16.74$29.00Overweight$0.0000.00% ROIMRUSMerus9/29/2025Reiterated Rating$94.15$97.00Equal Weight$0.0000.00% ROIMRUSMerus9/29/2025Downgrade$93.67$97.00Equal Weight$0.0000.00% ROIKNSAKiniksa Pharmaceuticals International9/25/2025Boost Price Target$36.27$45.00Overweight$00.0000.00% ROIRVMDRevolution Medicines9/11/2025Boost Price Target$40.45$70.00Overweight$000.0000.00% ROITrump's New Dollar (Ad)Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.Watch the free briefing and see the three steps to prepare todayXNCRXencor8/7/2025Lower Price Target$7.19$27.00Overweight$00.0000.00% ROIRCUSArcus Biosciences8/7/2025Lower Price Target$9.35$25.00Overweight$00.0000.00% ROIKNSAKiniksa Pharmaceuticals International7/9/2025Boost Price Target$28.07$42.00Overweight$00.0000.00% ROIIDYAIDEAYA Biosciences6/26/2025Initiated Coverage$22.01$44.00Overweight$00.0000.00% ROIRCUSArcus Biosciences5/7/2025Lower Price Target$7.34$26.00Overweight$00.0000.00% ROIBCAXBicara Therapeutics4/17/2025Initiated Coverage$11.76$8.00Underweight$00.0000.00% ROIXNCRXencor2/28/2025Lower Price Target$15.27$33.00Overweight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
